Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Profit After Tax (2022 - 2025)

Historic Profit After Tax for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to -$10.8 million.

  • TriSalus Life Sciences' Profit After Tax fell 35064.61% to -$10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$39.6 million, marking a year-over-year increase of 2877.86%. This contributed to the annual value of -$30.0 million for FY2024, which is 4938.77% up from last year.
  • As of Q3 2025, TriSalus Life Sciences' Profit After Tax stood at -$10.8 million, which was down 35064.61% from -$8.3 million recorded in Q2 2025.
  • TriSalus Life Sciences' Profit After Tax's 5-year high stood at $2.8 million during Q1 2022, with a 5-year trough of -$35.6 million in Q4 2023.
  • For the 4-year period, TriSalus Life Sciences' Profit After Tax averaged around -$9.6 million, with its median value being -$8.3 million (2025).
  • Data for TriSalus Life Sciences' Profit After Tax shows a peak YoY increase of 8239.22% (in 2023) and a maximum YoY decrease of 68560.77% (in 2023) over the last 5 years.
  • Quarter analysis of 4 years shows TriSalus Life Sciences' Profit After Tax stood at -$22.5 million in 2022, then plummeted by 58.1% to -$35.6 million in 2023, then soared by 71.64% to -$10.1 million in 2024, then fell by 6.95% to -$10.8 million in 2025.
  • Its Profit After Tax stands at -$10.8 million for Q3 2025, versus -$8.3 million for Q2 2025 and -$10.4 million for Q1 2025.